Eir Partners Acquires Controlling Stake in QuartzBio

EQT Healthcare Growth Agrees to Acquire Majority Stake in Europa Biosite

July 8, 2025

Healthcare Services

EQT Healthcare Growth has agreed to acquire a majority stake in Europa Biosite, a Stockholm-based distributor of research-use-only (RUO) life science reagents and biological substances. The agreement is intended to help Europa Biosite expand biospecimen offerings, strengthen local market presence, enter new regions, and invest in digital infrastructure.

Quanterix Completes Acquisition of Akoya Biosciences

July 8, 2025

Healthcare Services

Quanterix completed its previously announced acquisition of Akoya Biosciences under the amended merger agreement, issuing about 7.8 million shares and paying about $20 million in cash in the aggregate to Akoya holders. The companies positioned the deal as creating an integrated platform for measuring biomarkers across the blood and tissue continuum and expanding addressable markets.

IonQ Acquires Controlling Stake in ID Quantique

May 6, 2025

Cybersecurity

IonQ has completed the acquisition of a controlling stake in ID Quantique (IDQ), adding IDQ's quantum key distribution (QKD) systems, quantum random number generators (QRNGs) and single-photon detectors to its product portfolio. The deal expands IonQ's quantum networking and secure-communications capabilities, brings nearly 300 granted and pending patents to IonQ's IP estate, and strengthens its position in national and international quantum communications initiatives.

GI Partners Acquires Majority Stake in eClinical Solutions

September 12, 2024

Cloud & SaaS

GI Partners has made a majority investment in eClinical Solutions, a Boston‑area provider of AI‑enabled clinical data cloud software and biometrics services. The capital will support product roadmap expansion, embedded AI capabilities, and global growth while Summit Partners and the founders retain minority stakes.

Eir Partners Majority Recapitalizes PharmaForceIQ

September 10, 2024

Cloud & SaaS

Eir Partners completed a majority recapitalization of PharmaForceIQ (PFIQ), an AI-driven omnichannel orchestration and measurement platform for pharmaceutical and life science companies. The investment will fund product development, key hires and continued accumulation of data assets to scale PFIQ's HCP and DTC omnichannel offerings.

QuartzBio (Precision for Medicine) Acquires SolveBio

January 24, 2023

Cloud & SaaS

QuartzBio, a business unit of Precision for Medicine, has acquired SolveBio and integrated its enterprise biomarker and genomic data management platform into QuartzBio’s end-to-end SaaS suite. The acquisition expands QuartzBio’s capabilities for sample inventory, biomarker data management and enterprise-level visibility to better serve pharmaceutical and biotech clients in clinical research and development.